ORMP
Price
$4.67
Change
+$0.01 (+0.21%)
Updated
Sep 14 closing price
Capitalization
194.47M
62 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$5.01
Change
-$0.01 (-0.20%)
Updated
Sep 14 closing price
Capitalization
1.63B
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ORMP vs TSHA

ORMP vs TSHA Comparison Chart in %
View a ticker or compare two or three
VS
ORMP vs. TSHA commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and TSHA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.63B) has a higher market cap than ORMP($194M). TSHA has higher P/E ratio than ORMP: TSHA (2.70) vs ORMP (1.13). ORMP YTD gains are higher at: 75.768 vs. TSHA (-8.909). ORMP has higher annual earnings (EBITDA): 76M vs. TSHA (-148.42M). TSHA has more cash in the bank: 455M vs. ORMP (50.6M). ORMP has less debt than TSHA: ORMP (733K) vs TSHA (56.7M). TSHA has higher revenues than ORMP: TSHA (5.49M) vs ORMP (0).
ORMPTSHAORMP / TSHA
Capitalization194M1.63B12%
EBITDA76M-148.42M-51%
Gain YTD75.768-8.909-850%
P/E Ratio1.132.7042%
Revenue05.49M-
Total Cash50.6M455M11%
Total Debt733K56.7M1%
FUNDAMENTALS RATINGS
ORMP vs TSHA: Fundamental Ratings
ORMP
TSHA
OUTLOOK RATING
1..100
8953
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1598
PRICE GROWTH RATING
1..100
3759
P/E GROWTH RATING
1..100
9498
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (1) in the Pharmaceuticals Other industry is somewhat better than the same rating for TSHA (61) in the null industry. This means that ORMP’s stock grew somewhat faster than TSHA’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as TSHA (100) in the null industry. This means that ORMP’s stock grew similarly to TSHA’s over the last 12 months.

ORMP's SMR Rating (15) in the Pharmaceuticals Other industry is significantly better than the same rating for TSHA (98) in the null industry. This means that ORMP’s stock grew significantly faster than TSHA’s over the last 12 months.

ORMP's Price Growth Rating (37) in the Pharmaceuticals Other industry is in the same range as TSHA (59) in the null industry. This means that ORMP’s stock grew similarly to TSHA’s over the last 12 months.

ORMP's P/E Growth Rating (94) in the Pharmaceuticals Other industry is in the same range as TSHA (98) in the null industry. This means that ORMP’s stock grew similarly to TSHA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTSHA
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (ORMP: $4.67 vs. TSHA: $5.01)
Brand notoriety: ORMP and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 76% vs. TSHA: 90%
Market capitalization -- ORMP: $194.47M vs. TSHA: $1.63B
ORMP [@Biotechnology] is valued at $194.47M. TSHA’s [@Biotechnology] market capitalization is $1.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.68B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 2 FA rating(s) are green while TSHA’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 2 green, 3 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 2 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 5 bearish.
  • TSHA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than TSHA.

Price Growth

ORMP (@Biotechnology) experienced а -6.79% price change this week, while TSHA (@Biotechnology) price change was -10.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 16, 2026.

TSHA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ORMP
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMPIX37.68N/A
N/A
ClearBridge Appreciation FI
AGOCX14.31N/A
N/A
PGIM Jennison Global Equity Income C
FITIX26.46N/A
N/A
Fidelity Advisor Mid Cap II M
PAPPX31.47N/A
N/A
Papp Small & Mid-Cap Growth
RTDRX14.91-0.06
-0.40%
Russell Inv Multifactor US Equity R6

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with NGNE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-0.20%
NGNE - TSHA
47%
Loosely correlated
-0.76%
PRME - TSHA
46%
Loosely correlated
+1.60%
STOK - TSHA
44%
Loosely correlated
+1.96%
MGTX - TSHA
43%
Loosely correlated
+0.70%
ABEO - TSHA
43%
Loosely correlated
+0.28%
More